Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
CA Stock MarketDetailed Quotes
Vaxil Bio Ltd (VXL)
- 0.265
- 0.0000.00%
15min DelayMarket Closed May 15 16:00 ET
1.06MMarket Cap1.44P/E (TTM)
0.000High0.000Low71Volume0.265Open0.265Prev Close15.00Turnover0.32552wk High0.00%Turnover Ratio3.98MShares0.13052wk Low0.184EPS TTM996.49KFloat Cap196.000Historical High1.44P/E (Static)3.76MShs Float0.130Historical Low0.184EPS LYR0.00%Range %--Dividend TTM1.59P/B1Lot Size--Div Yield TTM
Vaxil Bio Ltd (VXL) Balance Sheet
Quarterly+Annual
YOY
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 49.78%671K | 49.78%671K | -16.45%447K | -41.09%347K | -56.20%403K | -52.24%448K | -52.24%448K | -46.98%535K | -44.64%589K | -31.45%920K |
| -Cash and cash equivalents | 49.78%671K | 49.78%671K | -16.45%447K | -41.09%347K | -56.20%403K | -52.24%448K | -52.24%448K | -46.98%535K | -44.64%589K | -31.45%920K |
| Receivables | -98.90%3K | -98.90%3K | -45.26%156K | 1.46%278K | 2,061.54%281K | 1,336.84%273K | 1,336.84%273K | 595.12%285K | 380.70%274K | -38.10%13K |
| -Accounts receivable | ---- | ---- | -55.56%12K | -50.00%12K | 15.38%15K | ---- | ---- | -34.15%27K | -57.89%24K | -38.10%13K |
| -Notes receivable | --0 | --0 | -44.19%144K | 6.40%266K | --266K | --266K | --266K | --258K | --250K | ---- |
| -Taxes receivable | -57.14%3K | -57.14%3K | ---- | ---- | ---- | -63.16%7K | -63.16%7K | ---- | ---- | ---- |
| Prepaid assets | -8.33%11K | -8.33%11K | ---- | ---- | ---- | -36.84%12K | -36.84%12K | ---- | ---- | ---- |
| Total current assets | -6.55%685K | -6.55%685K | -26.46%603K | -27.58%625K | -26.69%684K | -24.90%733K | -24.90%733K | -21.90%820K | -23.02%863K | -31.55%933K |
| Non current assets | ||||||||||
| Investments and advances | --685K | --685K | --72K | --72K | ---- | --0 | --0 | ---- | ---- | ---- |
| -Financial asset investment | --685K | --685K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| -Including:Available-for-sale securities | --685K | --685K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total non current assets | --685K | --685K | --72K | --72K | --0 | --0 | --0 | --0 | --0 | --0 |
| Total assets | 86.90%1.37M | 86.90%1.37M | -17.68%675K | -19.24%697K | -26.69%684K | -24.90%733K | -24.90%733K | -21.90%820K | -23.02%863K | -31.55%933K |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Current liabilities | -70.59%5K | -70.59%5K | -90.24%8K | -92.11%6K | -59.18%40K | -80.00%17K | -80.00%17K | -56.84%82K | -67.52%76K | -72.24%98K |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | -70.59%5K | -70.59%5K | -90.24%8K | -92.11%6K | -59.18%40K | -80.00%17K | -80.00%17K | -56.84%82K | -67.52%76K | -72.16%98K |
| Shareholders'equity | ||||||||||
| Share capital | 0.34%16.13M | 0.34%16.13M | 0.00%16.07M | 0.00%16.07M | 0.00%16.07M | 0.00%16.07M | 0.00%16.07M | 0.00%16.07M | 0.00%16.07M | 0.00%16.07M |
| -common stock | 0.34%16.13M | 0.34%16.13M | 0.00%16.07M | 0.00%16.07M | 0.00%16.07M | 0.00%16.07M | 0.00%16.07M | 0.00%16.07M | 0.00%16.07M | 0.00%16.07M |
| Retained earnings | 2.67%-19.01M | 2.67%-19.01M | -0.36%-19.58M | -0.51%-19.56M | -0.98%-19.61M | -0.92%-19.54M | -0.92%-19.54M | -0.67%-19.51M | -0.56%-19.46M | -0.97%-19.42M |
| Gains losses not affecting retained earnings | 0.00%4.18M | 0.00%4.18M | -0.02%4.18M | 0.07%4.18M | -0.02%4.18M | 0.07%4.18M | 0.07%4.18M | 8.63%4.18M | 8.66%4.18M | 8.72%4.18M |
| Other equity interest | --72K | --72K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total stockholders'equity | 90.64%1.37M | 90.64%1.37M | -9.62%667K | -12.20%691K | -22.87%644K | -19.64%716K | -19.64%716K | -14.19%738K | -11.27%787K | -17.41%835K |
| Total equity | 90.64%1.37M | 90.64%1.37M | -9.62%667K | -12.20%691K | -22.87%644K | -19.64%716K | -19.64%716K | -14.19%738K | -11.27%787K | -17.41%835K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm